Download PDF

Other users also viewed these articles

Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease Toshiya Machida; Taku Obara; Makoto Miyazaki; Jun Inoue; Nariyasu Mano;
10.1016/j.aohep.2022.100699
NAFLD: Challenges and opportunities to address the public health challenge in Latin America Juan Pablo Arab; Luis Antonio Díaz; Melisa Dirchwolf; Henry Mark; Jeffrey V. Lazarus; Elly Vaughan; Nahum Méndez-Sánchez; Claudia P. de Oliveira; Adrián Gadano; Marco Arrese;
10.1016/j.aohep.2021.100359
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589